Percutaneous coronary intervention-related periprocedural myocardial infarction (PCI-RPMI)
has now been definitively linked in large data sets to long-term adverse outcomes. It is more …

Lectin-like oxidized LDL receptor-1 (LOX-1) appears to play crucial roles in atherosclerotic
plaque rupture. We previously reported that circulating soluble LOX-1 (sLOX-1) levels are …

Cardiovascular diseases (CVDs), specifically lipid-driven atherosclerotic CVDs, remain the
number one cause of death worldwide. The lectin-like oxidized low-density lipoprotein (LDL) …

The Lectin-like OXidized low-density lipoprotein scavenger receptor (LOX-1) is implicated in
vascular inflammation and atherosclerotic plaque initiation, progression, and destabilization …

Atherosclerosis, the underlying cause of cardiovascular disease (CVD), is a worldwide
cause of morbidity and mortality. Reducing ApoB-containing lipoproteins—chiefly, LDL (low …

Background When the lectinlike oxidized low‐density lipoprotein (ox LDL) receptor‐1 (LOX‐
1), a scavenger receptor for ox LDL, binds ox LDL, processes leading to endothelial …

The lectin‐like oxidized low‐density lipoprotein receptor 1 (LOX‐1) expressed on vascular
cells plays a major role in atherogenesis by internalizing and degrading oxidized low …

Circulating levels of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1)
play an important role in the development and progression of atherosclerosis. We …

Aim: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is known to be a key
molecule in the pathogenesis of atherosclerosis. Although high levels of serum soluble LOX …

Endothelial activation and dysfunction induced by oxidized modified low‐density lipoprotein
(ox‐LDL) is one of the key steps in the initiation of atherosclerosis. Recent studies have …